Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

The normal human prostate does not significantly affect blood DHT levels.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Antiandrogen therapy helps treat genetic hair loss.

Mediterranean diet with fresh herbs and vegetables lowers male hair loss risk.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.